Primary liver cell carcinoma

disorder

SNOMED 1186630006CUI C2239176

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Interferon alfacon-1

substance

Interferon gamma-1b

substance

Interferon alfa-2a

substance

Interferon alfa-2b

substance

Peginterferon alfa-2b

substance

Peginterferon alfa-2a

substance

Sorafenib

substance

Sorafenib tosylate

substance

Regorafenib

substance

Atezolizumab

substance

Tremelimumab

substance

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Increased incidence of hepatocellular carcinoma

HP:0001402

Micronodular cirrhosis

HP:0001413

Subacute progressive viral hepatitis

HP:0006572

Related Conditions

Primary fibrolamellar hepatocellular carcinoma(child)

Primary hepatocholangiocarcinoma(child)

Hepatocarcinoma(parent)

Primary malignant neoplasm of liver(parent)

Primary adenocarcinoma of digestive organ(parent)

Quick Facts

SNOMED CT: 1186630006
UMLS CUI: C2239176
Fully Specified Name: Primary liver cell carcinoma (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
HPO Phenotypes: 3
Known Treatments: 11

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.